A Study to Evaluate Upadacitinib in Combination With Topical Corticosteroids in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis
a study on Atopic Dermatitis (Eczema)
Summary
- Eligibility
- for people ages 12-75 (full criteria)
- Location
- at UC Irvine
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- AbbVie
- Links
- This clinical study may be evaluating a usage that is not currently FDA approved.
- ID
- NCT03568318
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated